It was reported that the patient had open cardiac surgery with cardiopulmonary bypass (cpb).
The patient needed a double mitral-aortic valve replacement due to endocarditis.
It was noted that weaning off cpb was difficult and high drug support was required in the operating room (or) and while on cpb.
Intra-aortic balloon (iab) therapy was initiated to help support the weaning.
After insertion, a treatment by ecmo was performed of second-line in addition to iab therapy.
The patient was then transferred to the intensive care unit (icu).
After approximately two days of iab therapy, a leak occurred and blood was seen in the tubing.
It was also noted that the console had generated an alarm.
The iab was removed and replaced with a new one to continue therapy.
Despite the support, the patient expired due to their condition of endocarditis and double valve replacement.
This report of for the 2nd iab used.
A separate report has been submitted for the 1st iab under mfg report number 2248146-2022-00234.
|